Lumos Pharma Inc (LUMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 726 | 488 | 165 | 826 | 7 |
| Gross Profit | 726 | 488 | 165 | 826 | 7 |
| Operating Expenses | 8,366 | 8,311 | 11,027 | 10,830 | 8,939 |
| Operating Income | -7,640 | -7,823 | -10,862 | -10,004 | -8,932 |
| Other Income | 173 | 272 | 421 | 547 | 632 |
| Pre-tax Income | -7,467 | -7,551 | -10,441 | -9,457 | -8,300 |
| Net Income Continuous | -7,467 | -7,551 | -10,441 | -9,457 | -8,300 |
| Net Income | $-7,467 | $-7,551 | $-10,441 | $-9,457 | $-8,300 |
| EPS Basic Total Ops | -0.90 | -0.93 | -1.29 | -1.16 | -1.04 |
| EPS Basic Continuous Ops | -0.90 | -0.93 | -1.29 | -1.15 | -1.04 |
| EPS Diluted Total Ops | -0.90 | -0.93 | -1.29 | -1.16 | -1.04 |
| EPS Diluted Continuous Ops | -0.90 | -0.93 | -1.29 | -1.15 | -1.04 |
| EPS Diluted Before Non-Recurring Items | -0.90 | -0.93 | -1.29 | -1.17 | -1.04 |
| EBITDA(a) | $-7,641 | $-7,821 | $-10,860 | $-9,986 | $-8,924 |